Beta · prototype— This site is under construction: rankings, texts and features change every week.
UUback EN Follow the rankings Declare an interest

DST Global

Growth equity investor

Portfolio in 4 countries: 6 funded startups tracked by Uback, 6 of them in a ranking.

Portfolio on Uback6startups, 4 countries
In a ranking6ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedMar 2026Earendil Labs

Portfolio on Uback

Sorted by Uback rank, then Radar by last round
CompanyUbackSectorRound backedValuation (AI)
Danggeun (Karrot)#4 South KoreaCommerce › hyperlocal marketplaceSeries D · USD 162M · Aug 2021Unicorn
Earendil Labs#2 AI drug discoveryHealthtech › Biotech › AI drug discoveryEquity financing · USD 787M (several financing rounds) · Mar 2026Unicorn
Juicebox#3 RecruitingBusiness software › HR › RecruitingSeries B · USD 80M · Mar 2026Hundreds of M$
Poolside#4 Coding agentsArtificial intelligence › Agents › Coding agentsSeries B · USD 500M · Oct 2024Unicorn
Wayflyer#6 SME lendingFintech › Lending › SME lendingSeries B · USD 150M · Feb 2022Hundreds of M$
Nabla#11 Clinical softwareHealthtech › Clinical software › Clinical softwareSeries C · USD 70M · Jun 2025Hundreds of M$

Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.

By sector

Healthtech2
Artificial intelligence1
Business software1
Commerce1
Fintech1

Deals tracked per year

12021
12022
02023
12024
12025
22026

Co-investors

Dimension · INCE Capital · Sanofi · Biotech Development Fund · HV Capital · Bain Capital Ventures · eBay · NVIDIA · Sequoia Capital · Coatue · Y Combinator

Investors that joined the same rounds, as reported by public sources.

Sources. bloomberg.com, en.wikipedia.org, finance.yahoo.com, juicebox.ai, multiples.vc, prnewswire.com, statnews.com, techfundingnews.com, thenextweb.com, wewillcure.com, as cited on each company’s profile.

Last updated: Oct 2026Report a missing dealReport an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.